Previous Close | 0.2970 |
Open | 0.2818 |
Bid | 0.0000 x 800 |
Ask | 0.0000 x 3200 |
Day's Range | 0.2620 - 0.2970 |
52 Week Range | 0.1110 - 0.8300 |
Volume | |
Avg. Volume | 3,101,134 |
Market Cap | 8.694M |
Beta (5Y Monthly) | 0.79 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.0900 |
Earnings Date | Nov 13, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for BTTR
TAMPA, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced its research partner, Aimia Pet HealthCo. Inc. (APH), has signed a memorandum of understanding (MOU) with KGK Science Inc. (KGK) for the development of a GLP1 supplement for pets. The MOU sets out the basis for KGK to commence research and development of a GLP1 supplement for use in companion animals. Combining a GLP1 supplement
Third Quarter 2023 Revenue Grew 11% Year-Over-Year to $13.1 millionAdjusted EBITDA Growth of 95% Year-Over-Year EPS Growth of 77% Year-Over-Year TAMPA, FLORIDA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (“Better Choice” or the “Company”) (NYSE American: BTTR), a pet health and wellness company, today announced its results for the third quarter ended September 30, 2023 (“Q3 2023”). THIRD QUARTER 2023 FINANCIAL HIGHLIGHTS Revenue increased 24% from second quarter 2023, and 11%
TAMPA, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, and its research partner, Aimia Pet HealthCo Inc. (APH), today announced that APH has signed a memorandum of understanding (MOU) with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets. The MOU sets out the basis for Dr. Crosignani to commence research and development of a GLP1 supplement for use in companion animals. Combini